BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11595302)

  • 1. Human leucocyte antigen supertypes and immune susceptibility to HIV-1, implications for vaccine design.
    MacDonald KS; Matukas L; Embree JE; Fowke K; Kimani J; Nagelkerke NJ; Oyugi J; Kiama P; Kaul R; Luscher MA; Rowland-Jones S; Ndinya-Achola J; Ngugi E; Bwayo JJ; Plummer FA
    Immunol Lett; 2001 Nov; 79(1-2):151-7. PubMed ID: 11595302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HLA A2/6802 supertype is associated with reduced risk of perinatal human immunodeficiency virus type 1 transmission.
    MacDonald KS; Embree JE; Nagelkerke NJ; Castillo J; Ramhadin S; Njenga S; Oyug J; Ndinya-Achola J; Barber BH; Bwayo JJ; Plummer FA
    J Infect Dis; 2001 Feb; 183(3):503-6. PubMed ID: 11133384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection.
    MacDonald KS; Fowke KR; Kimani J; Dunand VA; Nagelkerke NJ; Ball TB; Oyugi J; Njagi E; Gaur LK; Brunham RC; Wade J; Luscher MA; Krausa P; Rowland-Jones S; Ngugi E; Bwayo JJ; Plummer FA
    J Infect Dis; 2000 May; 181(5):1581-9. PubMed ID: 10823757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA Class II Antigens and Their Interactive Effect on Perinatal Mother-To-Child HIV-1 Transmission.
    Luo M; Embree J; Ramdahin S; Bielawny T; Laycock T; Tuff J; Haber D; Plummer M; Plummer FA
    PLoS One; 2015; 10(5):e0126068. PubMed ID: 25945792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of peptide selection approaches for epitope-based vaccine design.
    Schubert B; Lund O; Nielsen M
    Tissue Antigens; 2013 Oct; 82(4):243-51. PubMed ID: 24461003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class I associations with rates of HIV-1 seroconversion and disease progression in the Pumwani Sex Worker Cohort.
    Peterson TA; Kimani J; Wachihi C; Bielawny T; Mendoza L; Thavaneswaran S; Narayansingh MJ; Kariri T; Liang B; Ball TB; Ngugi EN; Plummer FA; Luo M
    Tissue Antigens; 2013 Feb; 81(2):93-107. PubMed ID: 23330720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-G and mother-child perinatal HIV transmission.
    Luo M; Czarnecki C; Ramdahin S; Embree J; Plummer FA
    Hum Immunol; 2013 Apr; 74(4):459-63. PubMed ID: 23238215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.
    Kaslow RA; Rivers C; Tang J; Bender TJ; Goepfert PA; El Habib R; Weinhold K; Mulligan MJ;
    J Virol; 2001 Sep; 75(18):8681-9. PubMed ID: 11507213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission.
    MacDonald KS; Embree J; Njenga S; Nagelkerke NJ; Ngatia I; Mohammed Z; Barber BH; Ndinya-Achola J; Bwayo J; Plummer FA
    J Infect Dis; 1998 Mar; 177(3):551-6. PubMed ID: 9498431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection.
    Horton H; Frank I; Baydo R; Jalbert E; Penn J; Wilson S; McNevin JP; McSweyn MD; Lee D; Huang Y; De Rosa SC; McElrath MJ
    J Immunol; 2006 Nov; 177(10):7406-15. PubMed ID: 17082660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen class I supertypes and HIV-1 control in African Americans.
    Lazaryan A; Song W; Lobashevsky E; Tang J; Shrestha S; Zhang K; Gardner LI; McNicholl JM; Wilson CM; Klein RS; Rompalo A; Mayer K; Sobel J; Kaslow RA; ;
    J Virol; 2010 Mar; 84(5):2610-7. PubMed ID: 20032191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of human leukocyte antigen DRB with resistance or susceptibility to HIV-1 infection in the Pumwani Sex Worker Cohort.
    Lacap PA; Huntington JD; Luo M; Nagelkerke NJ; Bielawny T; Kimani J; Wachihi C; Ngugi EN; Plummer FA
    AIDS; 2008 May; 22(9):1029-38. PubMed ID: 18520346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA based selection of epitopes offers a potential window of opportunity for vaccine design against HIV.
    Sundaramurthi JC; Ashokkumar M; Swaminathan S; Hanna LE
    Vaccine; 2017 Oct; 35(42):5568-5575. PubMed ID: 28888341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
    Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
    J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk.
    Martinez DR; Vandergrift N; Douglas AO; McGuire E; Bainbridge J; Nicely NI; Montefiori DC; Tomaras GD; Fouda GG; Permar SR
    J Virol; 2017 May; 91(9):. PubMed ID: 28202762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leucocyte antigen (HLA)-DQB1*03:02 and HLA-A*02:01 have opposite patterns in their effects on susceptibility to HIV infection.
    Rallón N; Restrepo C; Vicario JL; Del Romero J; Rodríguez C; García-Samaniego J; García M; Cabello A; Górgolas M; Benito JM
    HIV Med; 2017 Sep; 18(8):587-594. PubMed ID: 28218480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades.
    Bird TG; Kaul R; Rostron T; Kimani J; Embree J; Dunn PP; Bwayo JJ; Plummer FA; Rowland-Jones SL; Dong T;
    AIDS; 2002 Sep; 16(14):1899-904. PubMed ID: 12351949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen-DQ alleles and haplotypes and their associations with resistance and susceptibility to HIV-1 infection.
    Hardie RA; Luo M; Bruneau B; Knight E; Nagelkerke NJ; Kimani J; Wachihi C; Ngugi EN; Plummer FA
    AIDS; 2008 Apr; 22(7):807-16. PubMed ID: 18427198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV vaccines in infants and children.
    Lambert JS
    Paediatr Drugs; 2005; 7(5):267-76. PubMed ID: 16220994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen (HLA)-C and its association with HIV-1 transmission in discordant couple and mother-to-child cohorts.
    Bardeskar NS; Chavan V; Ahir-Bist S; Nanavati R; Samant-Mavani P; Mehta P; Mania-Pramanik J
    Immunogenetics; 2018 Nov; 70(10):633-638. PubMed ID: 30128812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.